OPTH (Optimi Health) – DD on a psychedelic drug manufacturer that’s already generating revenue
Optimi Health (Nasdaq: OPTH) is a Health Canada-licensed manufacturer of GMP-grade psilocybin and MDMA capsules. Most psychedelic stocks are pre-revenue and dependent on trials. Optimi already sells finished-dose product to clinics in Australia, and it uplisted to Nasdaq in May …